Table 2. Age and anthropometric characteristics of the subjectsa.
| Group | Age (years) | Height (m) |
Weight (kg) |
Body mass index (kg/m2) |
||
|---|---|---|---|---|---|---|
| Baseline | 12 Weeks | Baseline | 12 Weeks | |||
| A n=8 (3 M, 5 F) | 71.1±2.7 | 1.68±0.11 | 75.6±15.3 | 76.7±15.9 | 26.6±3.8 | 26.8±3.9 |
| B n=8 (4 M, 4 F) | 71.9±3.0 | 1.67±0.08 | 74.4±12.7 | 74.8±12.2 | 26.7±3.4 | 26.8±3.3 |
| C n=9 (4 M, 5 F) | 71.8±2.7 | 1.64±0.10 | 70.5±12.4 | 70.8±12.1 | 26.3±3.9 | 26.4±3.9 |
| Average | 71.6±2.7 | 1.66±0.09 | 73.4±13.1 | 74.0±13.1 | 26.5±3.6 | 26.7±3.6 |
| F (2, 22) | 0.169 | 0.425 | 0.332 | 0.426 | 0.024 | 0.166 |
| P-value | 0.846 | 0.659 | 0.721 | 0.658 | 0.976 | 0.848 |
Abbreviations: A, standard essential amino-acid mixture (containing 20% leucine); B, modified amino-acid mixture (containing 40% leucine); C, placebo; F, female; M, male.
a
All values are means±standard deviation.